Participations à des congrès et colloques internationaux (28)
  1. 4. Alexandri, C., Stamatopoulos, B., Bareche, Y., Jabin, I., Bruylants, G., & Demeestere, I. (2019). Let-7a as a target to prevent chemotherapy-induced ovarian damage in mouse model: a novel & non-invasive pharmacological approach in future fertility preservation strategies. Poster présenté à la conférence EDT - Cancerology Annual Meeting (UCL) (06-09-2019: Brussels).
  2. 5. Alexandri, C., Stamatopoulos, B., Rothé, F., Devos, M., Retout, M., Daniel, A., Grosbois, J., & Demeestere, I. (2019). Identification and efficiency assessment of potential miRNAs targets for developing new pharmacological drugs against chemotherapy induced ovarian damage using mice model. Abstract session presented at Journée des doctorants(19: 25/04/2019: Faculté médecine, ULB)
  3. 6. Alexandri, C., Stamatopoulos, B., Rothé, F., Devos, M., Retout, M., & Demeestere, I. (2018). Identification and efficiency assessment of potential miRNAs targets for developing new pharmacological drugs against chemotherapy-induced ovarian damage using mice model. Poster présenté à la conférence Congress Drug Development (03-05/12/2018: San Francisco, USA).
  4. 7. Alexandri, C., Stamatopoulos, B., Rothé, F., & Demeestere, I. (2018). Identification and efficiency assessment of potential miRNAs targets for developing new pharmacological drugs against chemotherapy induced ovarian damage using mice model. Abstract session presented at U-CRC (ULB-Cancer Research Center)(3: 28 septembre 2018: Bruxelles, Belgique)
  5. 8. Alexandri, C., Stamatopoulos, B., Rothé, F., & Demeestere, I. (2018). Identification and efficiency assessment of potential miRNAs targets for developing new pharmacological drugs against chemotherapy induced ovarian damage using mice model. Paper session presented at Congress Bonding Embryologists to Fertility specialists to assist Nature in Overcoming Infertility (2nd: Thessaloniki, Greece).
  6. 9. Alexandri, C., Stamatopoulos, B., Rothé, F., & Demeestere, I. (2018). Identification and efficiency assessment of potential miRNAs targets for developing new pharmacological drugs against chemotherapy induced ovarian damage using mice model. 34th Annual Meeting of the European Society of Human Reproduction and Embryology: + Short Talk Presentation. Poster présenté à la conférence ESHRE (34th: 01-04/07/2018: Barcelona, Spain).
  7. 10. Alexandri, C., Stamatopoulos, B., Rothé, F., & Demeestere, I. (2018). Identification of potential miRNAs targets in mice model for developing new pharmacological drugs of chemotherapy induced ovarian damage. Poster présenté à la conférence TELEVIE’s Researchers Seminar.
  8. 11. Alexandri, C., Stamatopoulos, B., Rothé, F., & Demeestere, I. (2017). Identification of potential miRNAs targets in mice model for developing new pharmacological drugs of chemotherapy induced ovarian damage. Poster présenté à la conférence Belgian Society for Reproductive Medicine Meeting (38th: 01-02/12/2017: Brussels, Belgique).
  9. 12. Alexandri, C., Stamatopoulos, B., Rothé, F., & Demeestere, I. (2017). Identification of potential miRNAs targets in mice model for developing new pharmacological drugs of chemotherapy induced ovarian damage. Paper session presented at 38th BSRM meeting (1-2 december 2017: Brussels).
  10. 13. Alexandri, C., Stamatopoulos, B., Rothé, F., & Demeestere, I. (2017). Identification of potential miRNAs targets in mice model for developing new pharmacological drugs of chemotherapy induced ovarian damage. Poster présenté à la conférence Symposium de l’ULB-Cancer Research Center (2nd: 22/09/2017: Bruxelles, Belgium).
  11. 14. Stamatopoulos, B., et al. (2017). Deep sequencing reveals clinically relevant subclonal IGHV rearrangements in CLL. Paper session presented at Satellite Symposium of the 22th Congress of the European Hematology Association (EHA) (June 2017: Madrid, Spain).
  12. 15. Stamatopoulos, B., et al. (2017). The light chain IgLV3-21 defines a new poor prognostic subgroup in Chronic Lymphocytic Leukemia: a multicenter study. Paper session presented at Annual CLL UK Forum Scientific day (October 2017: London, United-Kingdom).
    13. << Précédent 1 2 3 4 5 6 7 Suivant >>